Atricure, INC Form 4 insider transactions

NASDAQ
AtriCure's Chief Scientific Officer, Vinayak Doraiswamy, reports acquisition and disposal of company stock related to restricted stock and performance share awards.
NASDAQ
Justin J. Noznesky, Chief Marketing & Strategy Officer at AtriCure, Inc., reports acquisition and disposal of company stock.
NASDAQ
AtriCure's Chief Technical Officer, Salvatore Privitera, reports acquisition and disposal of company stock related to restricted stock and performance share awards.
NASDAQ
Director Robert S. White exercised non-qualified stock options to acquire 10,000 shares of AtriCure, Inc. common stock at a price of $15.96 on February 23, 2024.